Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Varna – page 8

176 clinical trials in Varna, Bulgaria across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Varna at a glance
176
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

176 trials in Varna

Open in trial search
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Denosumab
  • Sponsor:Shandong Boan Biotechnology Co. Ltd.

Osteoarthritis

Not recruiting

Study on the Safety of RTX-GRT7039 and Ropivacaine Hydrochloride Injections for Patients with Moderate to Severe Knee Osteoarthritis Pain

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Resiniferatoxin
  • Sponsor:Gruenenthal GmbH

Study on the Effects of Budesonide, Glycopyrronium, and Formoterol in Patients Aged 40-80 with Chronic Obstructive Pulmonary Disease (COPD)

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Study on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer's Dementia Patients

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Quinidine Sulfate
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.

Study on the Effectiveness and Safety of CHF 5993 Compared to CHF 1535 for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Beclometasone Dipropionate Anhydrous
  • Sponsor:Chiesi Farmaceutici S.p.A.

Ischaemic stroke+2

Not recruiting

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Asundexian
  • Sponsor:Bayer AG

Arteriosclerosis

Not recruiting

Study on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Obicetrapib
  • Sponsor:NewAmsterdam Pharma B.V.

Multiple sclerosis

Not recruiting

Study Comparing CT-P53 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Methylprednisolone
  • Sponsor:Celltrion Inc.

Asthma

Not recruiting

Study on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:Chiesi Farmaceutici S.p.A.

Psoriatic arthropathy

Not recruiting

Study on Deucravacitinib for Patients with Active Psoriatic Arthritis New to Biologic Treatments

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Psoriatic arthropathy

Not recruiting

Study on Izokibep for Improving Symptoms in Patients with Active Psoriatic Arthritis

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Izokibep
  • Sponsor:Acelyrin Inc.

Endometriosis

Not recruiting

Study on the Effectiveness and Safety of OG-6219 and Naproxen Sodium for Women Aged 18-49 with Moderate to Severe Endometriosis Pain

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:FOR-6219
  • Sponsor:Organon LLC

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Varna

What the registry says about research in the country

01 Respiratory Medicine

Innovative clinical trials focusing on asthma management and treatments for moderate to severe cases, including studies of novel antibodies and improved inhaler formulations.

  • Uncontrolled asthma therapies
  • Anti-TSLP antibody treatments
  • Advanced inhaler technologies

Research aims to enhance breathing function and reduce exacerbations in patients with respiratory conditions.

02 Neurology & Mental Health

Comprehensive studies addressing multiple sclerosis, depression, and anxiety disorders, with trials evaluating both established and experimental therapeutic approaches.

  • Major Depressive Disorder treatment
  • Generalized Anxiety Disorder therapy
  • Multiple Sclerosis management

Focus on improving quality of life through innovative therapeutic interventions.

03 Cardiovascular & Metabolic

Studies targeting cardiovascular diseases and metabolic conditions, including trials for obesity management and stroke prevention.

  • Weight management therapies
  • Stroke prevention treatments
  • Chronic kidney disease interventions

Research aimed at reducing cardiovascular risks and improving metabolic health outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.